Trial Profile
Enfuvirtide for the Initial Phase of Antiretroviral Therapy in HIV-Infected Patients With High Risk of Clinical Progression : ANRS 130 APOLLO.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary) ; Efavirenz; Emtricitabine/tenofovir disoproxil fumarate; Lopinavir/ritonavir
- Indications HIV-1 infections
- Focus Registrational; Therapeutic Use
- Acronyms APOLLO; APOLLO-ANRS 130
- 19 Nov 2012 Results published in Antimicrobial Agents and Chemotherapy.
- 19 Nov 2012 Primary endpoint 'Immunological-response-rate' has not been met.
- 19 Feb 2010 Status changed from active, no longer recruiting to completed, results have been presented at CROI 2010.